Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers

John F. Pearson, Christopher Hakkaart, GEMO Study Collaborators, EMBRACE Collaborators, SWE-BRCA Investigators, kConFab Investigators, HEBON Investigators, Louise Marquart, Joe Dennis, George A.R. Wiggins, Daniel R. Barnes, Bridget A. Robinson, Peter D. Mace, Kristiina Aittomäki, Irene L. Andrulis, Banu K. Arun, Jacopo Azzollini, Judith Balmaña, Rosa B. Barkardottir, Sami BelhadjLieke Berger, Marinus J. Blok, Susanne E. Boonen, Julika Borde, Angela R. Bradbury, Joan Brunet, Saundra S. Buys, Maria A. Caligo, Ian Campbell, Wendy K. Chung, Kathleen B.M. Claes, Marie Agnès Collonge-Rame, Jackie Cook, Casey Cosgrove, Fergus J. Couch, Mary B. Daly, Sita Dandiker, Rosemarie Davidson, Miguel de la Hoya, Robin de Putter, Capucine Delnatte, Mallika Dhawan, Orland Diez, Yuan Chun Ding, Susan M. Domchek, Alan Donaldson, Jacqueline Eason, Douglas F. Easton, Hans Ehrencrona, Christoph Engel, D. Gareth Evans, Ulrike Faust, Lidia Feliubadaló, Florentia Fostira, John W.M. Martens

Research output: Contribution to journalArticleAcademicpeer-review

12 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers'. Together they form a unique fingerprint.

Biochemistry, Genetics and Molecular Biology